Sunesis Pharmaceutic (SNSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SNSS | AMGN | BMY | VRTX | GILD |
| Company | Sunesis Pharmaceutic | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 16.35 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 24.80 | 288.83 | 58.22 | 455.43 | 89.07 |
| Low | 16.35 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 18.62 | 285.62 | 57.83 | 446.25 | 88.49 |
| Change | +3.64 | -2.25 | -0.05 | -4.98 | -0.14 |
| % Change | +24.30% | -0.78% | -0.09% | -1.10% | -0.16% |
| Volume | 20,069,086 | 302,087 | 939,858 | 148,315 | 451,977 |
| 20-Day Average Volume | 6,608,405 | 2,756,853 | 12,065,878 | 1,272,419 | 7,343,237 |
| Previous Close | 14.98 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.35 | 307.16 | 55.91 | 479.02 | 90.81 |
| 20-Day Raw Stochastic | 62.71% | 17.58% | 66.02% | 1.00% | 16.22% |
| 20-Day Relative Strength | 78.29% | 33.55% | 60.04% | 39.72% | 49.91% |
| Weighted Alpha | +200.53 | -0.53 | +25.16 | +16.45 | +22.97 |
| Today's Opinion | 88% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 88% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 40% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +35.37% since 02/17/21 | -3.75% since 11/14/24 | -0.97% since 11/14/24 | -7.84% since 11/14/24 | -4.29% since 11/14/24 |
| Low | 3.53 on 02/22/21 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.25 on 11/21/24 | 86.08 on 11/19/24 |
| High | 7.09 on 02/24/21 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +75.58% since 01/22/21 | -10.08% since 10/21/24 | +11.15% since 10/21/24 | -6.71% since 10/21/24 | +2.17% since 10/21/24 |
| Low | 2.35 on 01/28/21 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.25 on 11/21/24 | 85.60 on 10/22/24 |
| High | 7.09 on 02/24/21 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +291.18% since 11/24/20 | -13.47% since 08/21/24 | +19.59% since 08/21/24 | -8.25% since 08/21/24 | +17.34% since 08/21/24 |
| Low | 1.33 on 11/25/20 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.25 on 11/21/24 | 75.35 on 08/22/24 |
| High | 7.09 on 02/24/21 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +92.27% since 08/24/20 | -9.54% since 05/21/24 | +37.05% since 05/21/24 | +0.90% since 05/21/24 | +31.02% since 05/21/24 |
| Low | 1.12 on 11/06/20 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 7.09 on 02/24/21 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 96,255 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 18,093 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 2,070,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -23,330,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | N/A | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | N/A | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 2.21 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 03/09/21 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |